WINNIPEG, Manitoba, Oct. 20, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”) today announced that the Toronto Stock Exchange (“TSX”) has approved the Company’s normal course issuer bid (the “NCIB”). Under the NCIB, the Company can purchase: (i) up to an aggregate of 2,802,503 common sharesContinue reading “Delta 9 Announces Normal Course Issuer Bid for Common Shares and Convertible Debentures”
Tag Archives: Delta 9
Delta 9 Enters Into Agreement to Acquire Saskatchewan Retail Cannabis Store
WINNIPEG, Manitoba, Oct. 19, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”) is pleased to announce that it has entered into an asset purchase agreement (the “Purchase Agreement”) to acquire from Auxly Cannabis Group Inc. and Kolab Project Inc. (collectively the “Vendors”) all or substantially allContinue reading “Delta 9 Enters Into Agreement to Acquire Saskatchewan Retail Cannabis Store”
Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner
WINNIPEG, Manitoba, Oct. 13, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that it has completed its final services milestone under an agreement with Saskatchewan based Micro Cultivation partner, VIGR Life Cannabis Inc. (“VIGR”). VIGR is an arm’s length third party inContinue reading “Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner”
Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner
WINNIPEG, Manitoba, Sept. 28, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that it has completed its final services milestone under an agreement with another Micro Cultivation partner, Prairie Trichomes. Prairie Trichomes is an arms length third party in which the CompanyContinue reading “Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner”
Delta 9 Increases Bank Credit Facilities to $22 Million
— DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that it has amended the Company’s credit facilities (the “Credit Facilities”) with Canadian Western Bank (the “Bank”) with the addition of new loan segments and amendments to certain existing loan segments. The amendments bring the Company’s totalContinue reading “Delta 9 Increases Bank Credit Facilities to $22 Million”
Delta 9 Reports Financials for Q2 2020
— DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month and six-month period ending June 30, 2020. Financial Highlights for the three-month period ending June 30, 2020 Net revenue of $13.0 million for the second quarter of 2020, an increaseContinue reading “Delta 9 Reports Financials for Q2 2020”
Delta 9 Provides Guidance & Timing for Q2 2020 Results
— DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”) is pleased to provide guidance on select financial results of the Company for the second quarter of 2020 based on preliminary results: The Company anticipates revenues for the three-month period ending June 30, 2020 to be between $12.7 million and $13.2Continue reading “Delta 9 Provides Guidance & Timing for Q2 2020 Results”
Delta 9 Enters into Cannabis Supply Agreement with Ontario Cannabis Store
— DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that on June 23, 2020 it entered into a Master Cannabis Supply Agreement (the “Agreement”) with Ontario Cannabis Retail Corporation (doing business as “Ontario Cannabis Store”) (“OCS”). The Agreement provides for the supply by Delta 9 ofContinue reading “Delta 9 Enters into Cannabis Supply Agreement with Ontario Cannabis Store”
Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process
— Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has filed a non-provisional patent with the USPTO for an “Apparatus for and method of converting cbd and/or cbd derivatives to at least one other type of cannabinoid and/orContinue reading “Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process”
